Breast, unspecified Clinical Trials

31 clinical trials for Breast, unspecified across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Non-Invasive Physical Plasma for Preventing Radiation Dermatitis in Breast Cancer: A Randomised Double-Blind Placebo-Controlled Trial — RECRUITING
• Tissue- and blood-based marker profiles for treatment response to combination treatment of surface hyperthermia and hypofractionated radiotherapy for locally recurrent breast carcinoma. — RECRUITING
• Genetic characterization of invasive lobular breast cancer and its metastases — RECRUITING
• Questionnaire study to identify initial symptoms and processes leading up to diagnosis in metastatic breast cancer — RECRUITING
• Male breast cancer - A prospective registry study the University Women's Hospital Magdeburg in cooperation with the GBG (German Breast Group) the diagnosis and treatment of breast cancer man — RECRUITING
• Assessment of Micro-Calcifications in magnified Specimen Radioraphy in Ductal Carcinoma in situ — RECRUITING
• Patients with Breast Cancer in Times of COVID-19 — RECRUITING
• Communication competencies of chronically ill patients in interaction with providers — RECRUITING
• Non-interventional Study to analyse the tolerability and effectiveness of a chemotherapy with taxanes (Eurotere® / Eurotaxel®) on an everyday basis to treat breast cancer — RECRUITING
• SWARM_Systemic release of growth factors after radioembolization of hepatic malignancies — OTHER
• ENABLE - Online-based Digital Measurement of Patient Satisfaction, Health Related Quality of Life and Pateint Reported Outcaomes in Breast Cancer — OTHER
• Estimation of the bicarbonate difference under optimal and real conditions in the neoadjuvant treatment of early breast cancer — NOT_YET_RECRUITING
• Non-invasive micro-RNA-based breast cancer diagnostics (Mammacheck) — OTHER
• Mindful walking in patients with breast cancer - a randomized pragmatic pilot study — OTHER
• Distribution of lymph node metastases in primary breast cancer — OTHER
• Epiflex in the immediate reconstruction with an implant after removal of the breast glandular tissue - a NOGGO - AWOGYN observational study — OTHER
• MA-DETECT — OTHER
• The effect of premature chemotherapy termination in breast cancer on relapse — OTHER
• Impact of patients’ refusal to undergo adjuvant treatment measures on survival — OTHER
• A Randomized, Experimental Evaluation Study of the Patient-Related, Medical, and Health Care Benefits of the Digital Therapy Companion "TINO DTB" (Therapy In Oncology Digital Therapy Companion). — NOT_YET_RECRUITING
• Effects of neoadjuvant and adjuvant therapy on sexual hormone levels, quality of life and sexual function in women with early breast cancer — OTHER
• Prospective trial for evaluation of potential heart dose reduction using deep inspiration breath-hold in radiotherapy of left-sided breast cancer — OTHER
• Quality of life after bilateral risk-reducing mastectomy and simultaneous reconstruction using pre-pectoral silicone implants, a prospective single centre analysis — OTHER
• Effects of combined strenght and endurance training (HIT and HIRT) on Energy-metabolism and genexpression in BRCA-Mutation Carriers — OTHER
• Effect of moderate running training and mindfulness based stress reduction (MBSR) on imme system and quality of life in women with breast cancer — OTHER
• Philips Digital Breast Tomosynthesis trial for CE markets — OTHER
• Sentinel node biopsy in breast cancer patients by means of indocyanin green — OTHER
• BRECA Male Study: Influences of targeted physical education on treatment side effects in men after breast cancer- a pilot study — OTHER
• Detection of chemotherapy / radiation induced myocardial damage using modern CMR techniques — NOT_YET_RECRUITING
• Single-arm, open-label, multicentre phase II study evaluating the efficacy and safety of BIBW 2992 (Afatinib) in combination with vinorelbine for the treatment of patients with metastatic breast cancer with intermediate HER2 expression (HER2 2+ by immunohistochemistry, fluorescence in-situ hybridisation (FISH) negative) after failure of first-line therapy in the metastatic setting and having been pre-treated with anthracyclines — OTHER
• "De novo" breast reconstruction with autologuos fat grafting in post-mastectomy patients — OTHER

Refine this search